Found: 10
Select item for more details and to access through your institution.
Afatinib plus osimertinib in the treatment of osimertinib-resistant non-small cell lung carcinoma: a phase I clinical trial.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-022-10467-w
- By:
- Publication type:
- Article
SMARCA4‐deficient undifferentiated tumor that responded to chemotherapy in combination with immune checkpoint inhibitors: A case report.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 15, p. 2264, doi. 10.1111/1759-7714.14547
- By:
- Publication type:
- Article
Massive digital gene expression analysis reveals different predictive profiles for immune checkpoint inhibitor therapy between adenocarcinoma and squamous cell carcinoma of advanced lung cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Statins can suppress DC‐mediated Th2 responses through the repression of OX40‐ligand and CCL17 expression.
- Published in:
- European Journal of Immunology, 2019, v. 49, n. 11, p. 2051, doi. 10.1002/eji.201847992
- By:
- Publication type:
- Article
The immunomodulatory-drug, lenalidomide, sustains and enhances interferon-α production by human plasmacytoid dendritic cells.
- Published in:
- Journal of Blood Medicine, 2019, v. 10, p. 217, doi. 10.2147/JBM.S206459
- By:
- Publication type:
- Article
Pembrolizumab-induced autoimmune encephalitis in a patient with advanced non-small cell lung cancer: A case report.
- Published in:
- Molecular & Clinical Oncology, 2019, v. 10, n. 2, p. 267
- By:
- Publication type:
- Article
Neutrophil-to-lymphocyte ratio as an early marker of outcomes in patients with advanced non-small-cell lung cancer treated with nivolumab.
- Published in:
- International Journal of Clinical Oncology, 2018, v. 23, n. 4, p. 634, doi. 10.1007/s10147-018-1250-2
- By:
- Publication type:
- Article
Retrospective analysis of single-agent nab-paclitaxel in patients with platinum-resistant non-small cell lung cancer.
- Published in:
- Molecular & Clinical Oncology, 2017, v. 7, n. 5, p. 803, doi. 10.3892/mco.2017.1392
- By:
- Publication type:
- Article
Guanosine and its modified derivatives are endogenous ligands for TLR7.
- Published in:
- International Immunology, 2016, v. 28, n. 5, p. 211, doi. 10.1093/intimm/dxv062
- By:
- Publication type:
- Article
Phase II study of pemetrexed and carboplatin plus bevacizumab, followed by maintenance pemetrexed and bevacizumab in Japanese patients with non-squamous non-small cell lung cancer.
- Published in:
- Oncology Letters, 2014, v. 8, n. 6, p. 2453, doi. 10.3892/ol.2014.2552
- By:
- Publication type:
- Article